Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation

M Nauck, GR Warnick, N Rifai - Clinical chemistry, 2002 - academic.oup.com
Abstract Background: Because LDL-cholesterol (LDL-C) is a modifiable risk for coronary
heart disease, its routine measurement is recommended in the evaluation and management …

[HTML][HTML] High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk

A Hafiane, J Genest - BBA clinical, 2015 - Elsevier
Plasma high density lipoprotein cholesterol (HDL) comprises a heterogeneous family of
lipoprotein species, differing in surface charge, size and lipid and protein compositions …

A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia

M Sampson, C Ling, Q Sun, R Harb, M Ashmaig… - JAMA …, 2020 - jamanetwork.com
Importance Low-density lipoprotein cholesterol (LDL-C), a key cardiovascular disease
marker, is often estimated by the Friedewald or Martin equation, but calculating LDL-C is …

Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels

A Sajja, J Park, V Sathiyakumar, B Varghese… - JAMA Network …, 2021 - jamanetwork.com
Importance Low-density lipoprotein cholesterol (LDL-C) is typically estimated with the
Friedewald or Martin/Hopkins equation; however, if triglyceride levels are 400 mg/dL or …

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

S Acton, A Rigotti, KT Landschulz, S Xu, HH Hobbs… - Science, 1996 - science.org
High density lipoprotein (HDL) and low density lipoprotein (LDL) are cholesterol transport
particles whose plasma concentrations are directly (LDL) and inversely (HDL) correlated …

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

U Laufs, V La Fata, J Plutzky, JK Liao - Circulation, 1998 - Am Heart Assoc
Background—Oxidized low-density lipoprotein (ox-LDL) causes endothelial dysfunction in
part by decreasing the availability of endothelial nitric oxide (NO). Although HMG CoA …

The Advanced glycation end product, N∊-(Carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions (∗)

MX Fu, JR Requena, AJ Jenkins, TJ Lyons… - Journal of Biological …, 1996 - ASBMB
N∊-(Carboxymethyl) lysine (CML) is an advanced glycation end product formed on protein
by combined nonenzymatic glycation and oxidation (glycoxidation) reactions. We now report …

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

U Laufs, JK Liao - Journal of Biological Chemistry, 1998 - ASBMB
The mechanism by which 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors
increase endothelial nitric oxide synthase (eNOS) expression is unknown. To determine …

[HTML][HTML] Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in …

TA Mori, V Burke, IB Puddey, GF Watts… - The American journal of …, 2000 - Elsevier
Background: Regular consumption of n− 3 fatty acids of marine origin can improve serum
lipids and reduce cardiovascular risk. Objective: This study aimed to determine whether …

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.

R Stocker, VW Bowry, B Frei - Proceedings of the National …, 1991 - National Acad Sciences
The temporal disappearance of natural antioxidants associated with human low density
lipoprotein (LDL) in relation to the appearance of various classes of lipid hydroperoxides …